文献速递类风湿关节炎

基质细胞中的糖皮质激素受体对糖皮质激素介导的关节炎炎症抑制至关重要

Glucocorticoid receptor in stromal cells is essential for glucocorticoid-mediated suppression of inflammation in arthritis.
PubMed 文献 · Ann Rheum Dis · 2018-07-11

该研究利用骨髓嵌合小鼠和GR二聚化缺陷小鼠,在血清转移诱导关节炎模型中探讨糖皮质激素受体在基质细胞中对炎症抑制的作用。结果显示免疫细胞中GR缺失不影响GC抑制关节炎,而基质细胞GR缺失或二聚化缺陷的小鼠对GC治疗抵抗,且GC无法刺激非经典非活化巨噬细胞及相关抗炎标志物。结论提出GC通过基质细胞(推测为成纤维样滑膜细胞)中GR二聚化依赖的基因调控发挥抗炎作用。

要点

  • 免疫细胞中糖皮质激素受体缺失不影响地塞米松对血清转移诱导关节炎的抑制。
  • 基质细胞中GR缺失或二聚化缺陷的小鼠对GC治疗抵抗,尽管细胞因子被有效抑制。
  • GC通过基质细胞GR二聚化依赖机制促进非经典抗炎巨噬细胞极化。

核心结论

  • GC的抗炎机制涉及非免疫基质细胞中GR二聚化依赖的基因调控,推测为成纤维样滑膜细胞。
  • 成纤维样滑膜细胞调控非经典抗炎巨噬细胞极化,有助于抑制关节炎炎症。

研究设计与样本

  • 研究使用缺乏造血或基质室GR的骨髓嵌合小鼠以及GR二聚化缺陷(GRdim)小鼠。
  • 在血清转移诱导关节炎(STIA)模型中分析地塞米松(1 mg/kg)治疗反应。
  • 检测关节肿胀、组织学细胞浸润、细胞因子、流式细胞术细胞组成和基因表达,并对野生型和GRdim原代小鼠成纤维样滑膜细胞进行RNASeq。

主要发现

  • 免疫细胞中GR缺失不损害GC介导的STIA抑制。
  • 基质细胞GR缺失或GR二聚化缺陷的小鼠对GC治疗抵抗,尽管细胞因子被有效抑制。
  • 在基质室GR功能受损小鼠中,GC未能刺激非经典非活化巨噬细胞(Ly6Cneg、MHCIIneg)及相关抗炎标志物CD163、CD36、AnxA1、MerTK和Axl。
  • 成纤维样滑膜细胞中GR缺失的小鼠对GC诱导的STIA抑制部分抵抗。
  • 对DEX处理的GRdim成纤维样滑膜细胞进行RNASeq分析显示独特基因特征,表明活性增强且未能降低巨噬细胞炎症蛋白(Mip)-1α和Mip-1β。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Glucocorticoid (GC) therapy is frequently used to treat rheumatoid arthritis due to potent anti-inflammatory actions of GCs. Direct actions of GCs on immune cells were suggested to suppress inflammation. OBJECTIVES: Define the role of the glucocorticoid receptor (GR) in stromal cells for suppression of inflammatory arthritis. METHODS: Bone marrow chimeric mice lacking the GR in the hematopoietic or stromal compartment, respectively, and mice with impaired GR dimerisation (GRdim) were analysed for their response to dexamethasone (DEX, 1 mg/kg) treatment in serum transfer-induced arthritis (STIA). Joint swelling, cell infiltration (histology), cytokines, cell composition (flow cytometry) and gene expression were analysed and RNASeq of wild type and GRdim primary murine fibroblast-like synoviocytes (FLS) was performed. RESULTS: GR deficiency in immune cells did not impair GC-mediated suppression of STIA. In contrast, mice with GR-deficient or GR dimerisation-impaired stromal cells were resistant to GC treatment, despite efficient suppression of cytokines. Intriguingly, in mice with impaired GR function in the stromal compartment, GCs failed to stimulate non-classical, non-activated macrophages (Ly6Cneg, MHCIIneg) and associated anti-inflammatory markers CD163, CD36, AnxA1, MerTK and Axl. Mice with GR deficiency in FLS were partially resistant to GC-induced suppression of STIA. Accordingly, RNASeq analysis of DEX-treated GRdim FLS revealed a distinct gene signature indicating enhanced activity and a failure to reduce macrophage inflammatory protein (Mip)-1α and Mip-1β. CONCLUSION: We report a novel anti-inflammatory mechanism of GC action that involves GR dimerisation-dependent gene regulation in non-immune stromal cells, presumably FLS. FLS control non-classical, anti-inflammatory polarisation of macrophages that contributes to suppression of inflammation in arthritis.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Koenen M, Culemann S, Vettorazzi S, et al. Glucocorticoid receptor in stromal cells is essential for glucocorticoid-mediated suppression of inflammation in arthritis. Ann Rheum Dis. 2018. PMID: 29997111. doi:10.1136/annrheumdis-2017-212762

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。